Inovio Pharma (INO) has discontinued its internally funded efforts to develop INO-4800 as a COVID-19 heterologous booster vaccine

Inovio Pharma (INO) has discontinued its internally funded efforts to develop INO-4800 as a COVID-19 heterologous booster vaccine
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.